by Danielle Bonadies | Apr 16, 2020 | Press Releases
Easy-to-understand genetic counseling reports will lead to more appropriate follow-up and better health outcomes. NEW HAVEN, CONN. (PRWEB) APRIL 16, 2020 More than 600 people undergo genetic counseling and testing each year as part of the Neag Comprehensive Cancer...
by Danielle Bonadies | Feb 6, 2020 | News
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
by Danielle Bonadies | Jan 24, 2020 | News
A few months ago, I received an email from a company called Chronomics that tests for epigenetic changes in your DNA. I’m still a bit scarred from my personal direct-to-consumer testing experience, so I was initially reluctant to explore yet another genetic...
by Danielle Bonadies | Jan 2, 2020 | News
2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
